Skip to content

Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19

January 31, 2021

From the National Public Radio website

A global study of nearly 44,000 found that the COVID-19 vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease.

The study was conducted in the U.S., Latin America and South Africa. The vaccine did better at preventing disease in the U.S. – 72% — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.

Continue reading

From → Health & Safety

Comments are closed.